During the past decade, Ginger-K Lymphedema & Cancer Center conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ginger-K Lymphedema & Cancer Center" are "Lymphedema" (3 trials), "Lymphedema of Upper Arm" (2 trials), "Breast Cancer Related Lymphedema" (1 trials), "Chronic Venous Insufficiency" (1 trials) and "Lymphedema Lower Extremity" (1 trials). Many other conditions were trialed in "Ginger-K Lymphedema & Cancer Center" in a lesser frequency.

Most popular intervention types in "Ginger-K Lymphedema & Cancer Center" are "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Crossover Device (PCD or Dayspring - alternate to first group)" (1 trials), "Dayspring Active Wearable Compression System" (1 trials) and "User of Dayspring device" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ginger-K Lymphedema & Cancer Center" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Ginger-K Lymphedema & Cancer Center". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Ginger-K Lymphedema & Cancer Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ginger-K Lymphedema & Cancer Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".